← Back to Search

Topical Agent

0.375% (w/w) MTC896 Gel for Acne

Phase 2

Waitlist Available

Research Sponsored by Mimetica Pty Limited

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up weeks 4, 8 and 12

Awards & highlights

Study Summary

This study is designed to investigate the efficacy, safety and tolerability of MTC896 Gel in subjects with acne. In this study, MTC896 Gel will be applied at 3 concentrations, twice daily (bid) for 12 weeks and compared against a vehicle control.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ weeks 4, 8 and 12

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~weeks 4, 8 and 12

This trial's timeline: 3 weeks for screening, Varies for treatment, and weeks 4, 8 and 12 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Proportion of subjects with Investigator"s Global Assessment (IGA) success

Secondary outcome measures

Absolute change from baseline in inflammatory lesion counts

Absolute change from baseline in noninflammatory lesion counts

Absolute change from baseline in total lesion counts

+7 more

Trial Design

4Treatment groups

Experimental Treatment

Placebo Group

Group I: 1.5% (w/w) MTC896 GelExperimental Treatment1 Intervention

1.5% (w/w) MTC896 Gel will be applied bid to the whole face for 12 weeks.

Group II: 0.75% (w/w) MTC896 GelExperimental Treatment1 Intervention

0.75% (w/w) MTC896 Gel will be applied bid to the whole face for 12 weeks.

Group III: 0.375% (w/w) MTC896 GelExperimental Treatment1 Intervention

0.375% (w/w) MTC896 Gel will be applied bid to the whole face for 12 weeks.

Group IV: Vehicle Control GelPlacebo Group1 Intervention

Vehicle Control Gel will be applied bid to the whole face for 12 weeks.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Mimetica Pty LimitedLead Sponsor

2 Previous Clinical Trials

167 Total Patients Enrolled

Debra DowStudy DirectorSymbio, LLC

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What site did they apply to?

NCT02395549

What portion of applicants met pre-screening criteria?

Met criteria

What questions have other patients asked about this trial?

How many times will I have to visit in person?

PatientReceived 2+ prior treatments

Why did patients apply to this trial?

I've tried a LOT of treatments and they haven't worked. My acne and anxiety feed off of each other. Recently I've been avoiding socializing because my acne is so bad. I feel unattractive, down, and hopeless about things improving.

PatientReceived no prior treatments

Recent research and studies

clinicaltrials.govStudy

A Study to Determine the Efficacy of Topically Applied MTC896 Gel in Subjects With Acne Vulgaris

2015. "A Study to Determine the Efficacy of Topically Applied MTC896 Gel in Subjects With Acne Vulgaris". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02395549.

All > Acne